All In Biotech

Free tool

FAERS Monitor: Tybost

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203094 or its brand name (Tybost, Cobicistat). Reports on generic versions are filed under their own applications.

Reports

621

Serious

582

94% of reports

Hospitalization

194

Death reported

64

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction181
  • cushing^s syndrome60
  • foetal exposure during pregnancy48
  • immune reconstitution inflammatory syndrome38
  • serotonin syndrome36
  • adrenal insufficiency32
  • off label use29
  • anxiety26
  • drug ineffective25
  • pain25
  • virologic failure24
  • emotional distress22
  • acute kidney injury20
  • anhedonia20
  • depression20

Reports by year received

View as table
YearReports
20101
20122
20135
201413
201511
201637
201733
201844
201983
202082
202141
202280
202361
202460
202550
202618

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,538 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
immune reconstitution inflammatory syndromeSignal38260.3191.09,486
virologic failureSignal24151.8102.53,432
adrenal insufficiencySignal3289.563.92,708
serotonin syndromeSignal3663.646.32,154
drug interactionSignal18138.734.26,650
anhedoniaSignal2025.816.8452
foetal exposure during pregnancySignal4820.015.2851
emotional distressSignal226.24.190
acute kidney injurySignal204.42.950
anxietySignal263.12.135
depressionSignal203.01.925
pain251.40.92
off label use291.10.80
drug ineffective250.60.45
cushing^s syndrome600.00.02,000,402

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.